Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study

被引：2
|
作者：
Strickler, J. H. [1 ]
Hsu, L-I. [2 ]
DeBusk, K. [2 ]
Wright, P. [2 ]
Stecher, M. [3 ]
Siadak, M. [4 ]
Palanca-Wessels, M. C. [3 ]
Yu, J. [5 ]
Zhang, N. [6 ]
Espenschied, C. R. [7 ]
Lang, K. [6 ]
Bekaii-Saab, T. [8 ]
机构：
[1] Duke Canc Ctr, Div Med Oncol, Durham, NC USA
[2] Seagen Inc, Global Hlth Econ & Outcomes Res, Bothell, WA USA
[3] Seagen Inc, Clin Dev, Bothell, WA USA
[4] Seagen Inc, Med Affairs, Bothell, WA USA
[5] Guardant Hlth Inc, Clin Dev, Redwood City, CA USA
[6] Guardant Hlth Inc, Outcomes & Evidence, Redwood City, CA USA
[7] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA
[8] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [41] Neratinib has clinical activity in HER2-amplified breast cancer patients with tumors that have acquired activating mutations in HER2
    Cocco, Emiliano
    Carmona, F. Javier
    Won, Helen H.
    Berger, Michael F.
    Hyman, David M.
    Rossi, Valentina
    Chan, Carmen
    Moriarty, Alyssa
    Papadopoulos, Kyriakos P.
    Wick, Michael J.
    Cownie, James
    Sarotto, Ivana
    Cutler, Richard E.
    Avogadri-Connors, Francesca
    Savas, Peter
    Lalani, Alshad S.
    Boni, Valentina
    Loi, Sherene
    Baselga, Jose
    Montemurro, Filippo
    Scaltriti, Maurizio
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [42] Treatment patterns and costs in second-line (2L) metastatic colorectal cancer (mCRC)
    Teitelbaum, April H.
    Evans, Dana
    Yu, Elaine
    Morlock, Robert
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [43] Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm
    Narita, Yusuke
    Yoshimoto, Takuya
    Namai, Tomoyuki
    Asakawa, Takashi
    Kawakami, Satoe
    Gower-Page, Craig
    Reyes-Rivera, Irmarie
    Patel, Arisha
    Nakamura, Yoshiaki
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [44] A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
    Jia, Jingquan
    Moyer, Ashley
    Lowe, Melissa
    Bolch, Emily
    Kortmansky, Jeremy
    Cho, May
    Lenz, Heinz-Josef
    Kalyan, Aparna
    Niedzwiecki, Donna
    Strickler, John H.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [45] A systematic review to assess the efficacy of HER2-targeted treatment regimens in HER2positive metastatic colorectal cancer (mCRC).
    Bakhtiar, Muhammad
    Gholami, Sepideh
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 166 - 166
  • [46] Real-world treatment patterns and clinical outcomes among patients with HR+/HER2-advanced/metastatic breast cancer receiving palbociclib in Brazil: IRIS study
    Simon, Patricia
    Guarin, Alexandra
    Jain, Ankita
    Piton, Luciana
    Lima, Julia
    Carvalho, Carla Fabrine
    Nazareth, Felipe
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Dermatological toxicities of panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC) from three clinical studies
    Drelich, D. A.
    Rose, L.
    Ramirez, M.
    Jacobs, M.
    Mitchell, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature
    Thorpe, Lauren M.
    Schrock, Alexa B.
    Erlich, Rachel L.
    Miller, Vincent A.
    Knost, James
    Le-Lindqwister, Nguyet
    Jujjavarapu, Srinivas
    Ali, Siraj M.
    Liu, Jane J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (03): : E40 - E44
  • [49] Dermatological toxicities with panitumumab for the treatment of patients with metastatic colorectal cancer (MCRC) from three clinical studies
    Mitchell, E.
    Rose, L.
    Ramirez, M.
    Jacobs, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII82 - VII83
  • [50] Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature
    May, Michael
    Raufi, Alexander G.
    Sadeghi, Sina
    Chen, Karen
    Iuga, Alina
    Sun, Yu
    Ahmed, Firas
    Bates, Susan
    Manji, Gulam A.
    ONCOLOGIST, 2021, 26 (08): : 640 - 646
12345